Completed PHASE2 INTERVENTIONAL 2-arm NCT00935610

Effect of Immunocal® With Exercise Versus Casein With Exercise on Aging Processes in Elderly Persons

Effect of the Cysteine-rich Whey Protein Isolate (Immunocal®) in Combination With Physical Exercise on Muscle Function, Body Composition and Inflammatory Cytokine Levels in Elderly Persons: A Randomized, Double-blind Study

Sponsor: Immunotec Inc.

Conditions Aging Sarcopenia

Interventions Casein Immunocal

Updated 6 times since 2017 Last updated: Feb 8, 2021 Started: Jun 30, 2009 Primary completion: Jul 31, 2013 Completion: Mar 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Aging and Sarcopenia and is currently completed. Immunotec Inc. leads this study, which shows 6 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Mar 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Mar 2021 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Immunotec Inc.

Data source: Immunotec Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada